Of relevance, heightened MAPK > ERK signaling drives the expression of these feedback inhibitors24 and DUSP6 and SPRY2 levels are elevated in human skin cancers (Supplementary Fig. 6a). This evidence concerns the gene DUSP6 and skin neoplasm.